TORONTO--(BUSINESS WIRE)--Sept. 18, 2008--Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company will present at the at the CIBC World Markets 7th Annual Eastern Institutional Conference at Le Centre Sheraton Hotel in Montreal, Quebec and the UBS 2008 Global Life Sciences Conference at the Grand Hyatt New York Hotel in New York City.
Biovail's CIBC presentation is scheduled for Tuesday, September 23, 2008 at 8 a.m. EDT. The UBS presentation is scheduled for Wednesday, September 24, 2008 at 8:00 a.m. EDT. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
CONTACT:
Biovail Corporation Nelson F. Isabel,
(905) 286-3000 Vice President,
Investor Relations & Corporate Communications
